title: Characterization of the melanoma brain metastatic niche in mice and humans.
abstract: Brain metastases occur in 15% of patients with melanoma and are associated with a dismal prognosis. Here, we investigate the architectural phenotype and stromal reaction of melanoma brain metastasis in mice and humans. A syngeneic, green fluorescence protein (GFP)-expressing murine B16-F1 melanoma clone was introduced via intracardiac injection, and was examined in vivo in comparison with human specimens. Immunofluorescence analyses of the brain metastases revealed that F4/80(+) macrophages/microglia were most abundant at the tumor front, but rare in its core, where they were found only around blood vessels (P = 0.01). Similar pattern of infiltration was found in CD3(+) T cells (P < 0.01). Infiltrating T cells were prominently CD4(+) compared with CD8(+) T cells (P < 0.001). Blood vessels (CD31(+)) were less abundant at the tumor front than in its center (12 ± 1 vs. 4 ± 0.6 vessels per high-power field [HPF], P < 0.001). In contrast, there were few vessels at the tumor front, but their diameter was significantly larger at the front (8236 μm(2) vs. 4617 μm(2) average cross-sectional area, P < 0.005). This is the first comparative analysis of melanoma brain metastases showing similar stromal reaction in murine models and human specimens. Our results validate the utility of this murine model of melanoma brain metastases for investigating the mechanism of the human disease.
authors: Laboratory for Applied Cancer Research, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University,Tel Aviv, Israel.
authors: Moran
authors: M
authors: Amit
authors: Leonor
authors: L
authors: Laider-Trejo
authors: Vardit
authors: V
authors: Shalom
authors: Ayelet
authors: A
authors: Shabtay-Orbach
authors: Yakov
authors: Y
authors: Krelin
authors: Ziv
authors: Z
authors: Gil
mesh_terms: D000818:Animals; D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000556:secondary*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D045744:Cell Line, Tumor; D005260:Female; D005455:Fluorescent Antibody Technique; D049452:Green Fluorescent Proteins / Q000235:genetics; D006801:Humans; D008546:Melanoma, Experimental / Q000556:secondary*; D051379:Mice; D008810:Mice, Inbred C57BL; D012878:Skin Neoplasms / Q000473:pathology*
chemical_list: D049452:Green Fluorescent Proteins
keywords: Cancer biology; clinical cancer research
references: Microvasc Res. 1998 Jul;56(1):1-21
references: 9683559
references: J Pathol. 2002 Mar;196(3):254-65
references: 11857487
references: Cancer Res. 2002 Mar 1;62(5):1326-9
references: 11888900
references: Microvasc Res. 2010 May;79(3):169-73
references: 20149806
references: N Engl J Med. 2008 Jul 31;359(5):492-507
references: 18669428
references: PLoS Med. 2005 Sep;2(9):e284
references: 16124834
references: Nature. 2009 Jun 18;459(7249):1005-9
references: 19421193
references: J Clin Invest. 2007 May;117(5):1137-46
references: 17476343
references: Cancer Cell. 2005 Sep;8(3):211-26
references: 16169466
references: J Pathol. 1998 Feb;184(2):119-22
references: 9602700
references: N Engl J Med. 1991 Jan 3;324(1):1-8
references: 1701519
references: Am J Pathol. 2010 Jun;176(6):2958-71
references: 20382702
references: Gene Ther. 1999 Jul;6(7):1305-12
references: 10455440
references: Microvasc Res. 1996 Mar;51(2):260-72
references: 8778579
references: Science. 2006 Sep 29;313(5795):1960-4
references: 17008531
references: Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12530-5
references: 19617536
references: Clin Exp Metastasis. 2008;25(7):799-810
references: 18649117
references: J Natl Cancer Inst Monogr. 2001;(28):10-4
references: 11158201
references: Lancet Oncol. 2002 Jan;3(1):53-7
references: 11905606
references: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references: 19474385
references: Cancer. 2002 May 15;94(10):2698-705
references: 12173339
references: J Natl Cancer Inst. 1976 Nov;57(5):1199-202
references: 1003551
references: Mol Med. 2006 Jul-Aug;12(7-8):161-70
references: 17088948
references: J Natl Cancer Inst. 2007 Nov 7;99(21):1583-93
references: 17971532
references: Oncogene. 1999 Sep 20;18(38):5356-62
references: 10498889
references: Cell. 2009 Dec 24;139(7):1315-26
references: 20064377
references: Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10666-71
references: 19541645
references: Int J Cancer. 2008 Aug 1;123(3):609-15
references: 18498132
references: J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S78-86
references: 22018071
references: Cytometry A. 2008 Mar;73(3):186-93
references: 18000872
references: Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18538-43
references: 16344461
references: Anticancer Res. 2004 Jan-Feb;24(1):37-42
references: 15015573
references: BMC Cancer. 2009 Mar 26;9:95
references: 19323831
references: Cancer Res. 1995 Jan 15;55(2):376-85
references: 7529135
references: N Engl J Med. 2005 Dec 22;353(25):2654-66
references: 16371631
references: J Leukoc Biol. 2004 Mar;75(3):388-97
references: 14612429
references: Cancer Res. 1998 Aug 15;58(16):3491-4
references: 9721846
references: Lancet Oncol. 2009 Sep;10(9):877-84
references: 19656725
references: J Mammary Gland Biol Neoplasia. 2002 Apr;7(2):177-89
references: 12463738
references: Cancer Cell. 2003 Aug;4(2):133-46
references: 12957288
references: Mol Cell Biol. 2000 Jun;20(11):4106-14
references: 10805752
references: Nature. 1980 Jan 10;283(5743):139-46
references: 6985715
references: Microsc Res Tech. 2001 Jul 15;54(2):106-13
references: 11455617
references: J Mammary Gland Biol Neoplasia. 2002 Apr;7(2):147-62
references: 12465600
references: Neurol Res. 2005 Oct;27(7):685-91
references: 16197805
references: Cancer. 1996 Apr 1;77(7):1303-10
references: 8608507